Paradoxical Activation of T Cells via Augmented ERK Signaling Mediated by a RAF Inhibitor

Cancer immunology research - United States
doi 10.1158/2326-6066.cir-13-0160
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

Time-Resolved Phosphoproteome Analysis of Paradoxical RAF Activation Reveals Novel Targets of ERK

Molecular and Cellular Proteomics
BiochemistryMedicineAnalytical ChemistryMolecular Biology
2017English

Combination of a Selective HSP90α/β Inhibitor and a RAS-RAF-MEK-ERK Signaling Pathway Inhibitor Triggers Synergistic Cytotoxicity in Multiple Myeloma Cells

PLoS ONE
Multidisciplinary
2015English

Activation of CD4 T Cells by Raf-Independent Effectors of Ras

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2003English

Next-Generation RAF Inhibitors Prevent Paradoxical MAPK Activation

Cancer Discovery
Oncology
2015English

930 SOX2 Epidermal Overexpression Promotes Cutaneous Wound Healing via Activation of EGFR/MEK/ERK Signaling Mediated by EGFR Ligands

Journal of Investigative Dermatology
BiochemistryDermatologyCell BiologyMolecular Biology
2019English

EIF5A1 Promotes Trophoblast Migration and Invasion via ARAF-mediated Activation of the Integrin/Erk Signaling Pathway

Cell Death and Disease
Molecular NeuroscienceImmunologyCell BiologyCancer ResearchCellularMedicine
2018English

Molecular Signaling in Multiple Myeloma: Association of RAS/RAF Mutations and MEK/ERK Pathway Activation

Oncogenesis
Cancer ResearchMolecular Biology
2017English

Neural Stem Cells Secrete Factors Facilitating Brain Regeneration Upon Constitutive Raf-Erk Activation

Scientific Reports
Multidisciplinary
2016English

Receptor Heterodimerization Leads to a Switch in Signaling: -Arrestin2-Mediated ERK Activation by - Opioid Receptor Heterodimers

FASEB Journal
BiochemistryBiotechnologyGeneticsMolecular BiologyMedicine
2007English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy